Voyageur Pharmaceuticals Ltd.
VYYRF
$0.08
$0.000.00%
OTC PK
| 02/28/2026 | 11/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2,720.00% | -93.75% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2,720.00% | -93.75% | |||
| Cost of Revenue | 981.25% | -115.84% | |||
| Gross Profit | -100.00% | 195.24% | |||
| SG&A Expenses | -23.87% | -26.93% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -21.14% | -28.07% | |||
| Operating Income | 23.59% | 27.38% | |||
| Income Before Tax | 25.83% | 34.79% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 25.83% | 34.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 25.83% | 34.79% | |||
| EBIT | 23.59% | 27.38% | |||
| EBITDA | 23.60% | 27.39% | |||
| EPS Basic | 25.71% | 38.60% | |||
| Normalized Basic EPS | 27.27% | 38.89% | |||
| EPS Diluted | 25.71% | 38.60% | |||
| Normalized Diluted EPS | 27.27% | 38.89% | |||
| Average Basic Shares Outstanding | 0.12% | 6.52% | |||
| Average Diluted Shares Outstanding | 0.12% | 6.52% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||